OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors
Lei Peng, Giacomo Sferruzza, Luojia Yang, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 10, pp. 1089-1108
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Advances in Cell and Immune Therapies for Melanoma
Tanase Timis, Sanda Buruiana, Delia Dima, et al.
Biomedicines (2025) Vol. 13, Iss. 1, pp. 98-98
Open Access | Times Cited: 1

SMAD4 Regulates the Expression of LCK Affecting Chimeric Antigen Receptor‐T Cells Proliferation Through PI3K/Akt Signaling Pathway
Rongxue Wan, Bowen Fu, Xuemei Fu, et al.
Journal of Cellular Physiology (2025) Vol. 240, Iss. 1
Open Access | Times Cited: 1

Chimeric Cytokine Receptor TGF-β RⅡ/IL-21R Improves CAR-NK Cell Function by Reversing the Immunosuppressive Tumor Microenvironment of Gastric Cancer
Yaojun Ren, Min Xue, Xinhui Hui, et al.
Pharmacological Research (2025) Vol. 212, pp. 107637-107637
Open Access | Times Cited: 1

Are monocytes a preferable option to develop myeloid cell-based therapies for solid tumors?
Daisy Bhatia, Riccardo Dolcetti, Roberta Mazzieri
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1

Engineering innate immune cells for cancer immunotherapy
Mubin Tarannum, Xizhong Ding, Marta Barisa, et al.
Nature Biotechnology (2025) Vol. 43, Iss. 4, pp. 516-533
Closed Access | Times Cited: 1

Allogeneic chimeric antigen receptor cell therapies for cancer: progress made and remaining roadblocks
Caroline Diorio, David T. Teachey, Stephan A. Grupp
Nature Reviews Clinical Oncology (2024)
Closed Access | Times Cited: 8

Evaluation of efficacy, safety and underlying mechanism on Traditional Chinese medicine as synergistic agents for cancer immunotherapy: A preclinical systematic review and meta-analysis
Jing Li, Shipeng Fan, Hongxia Li, et al.
Journal of Ethnopharmacology (2024) Vol. 338, pp. 119035-119035
Closed Access | Times Cited: 6

Recent Advances in Anticancer Strategies
Zhiwei Hu, Hassan Bousbaa
Cancers (2025) Vol. 17, Iss. 2, pp. 173-173
Open Access

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
Markéta Skaličková, Katerina Hadrava Vanova, Ondřej Uher, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access

Translational study of the regulatory mechanism by which immune synapses enhance immune cell function
Yahui Li, Xiao‐Jun Huang, Xiang‐Yu Zhao
Cancer Letters (2025) Vol. 614, pp. 217542-217542
Closed Access

NK cells in renal cell carcinoma and its implications for CAR-NK therapy
Xinwei Li, Yuanpeng Zhang, Yuzhong Ye, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

The Emerging Role of CD8+ T Cells in Shaping Treatment Outcomes of Patients with MDS and AML
Athanasios Tasis, Theodoros Spyropoulos, Ioannis Mitroulis
Cancers (2025) Vol. 17, Iss. 5, pp. 749-749
Open Access

A 5-Year Update on the Clinical Development of Cancer Cell-Based Vaccines for Glioblastoma Multiforme
Almohanad A. Alkayyal, Ahmad Bakur Mahmoud
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 376-376
Open Access

CDH17-targeting CAR-NK cells synergize with CD47 blockade for potent suppression of gastrointestinal cancers
Liuhai Zheng, Yingqiao Ding, Xiaolong Xu, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

The Role of Killer Ig-like Receptors in Diseases from A to Z
Luisa Agnello, Anna Masucci, Martina Tamburello, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3242-3242
Open Access

The Role of NK Cells in Cancer Immunotherapy: Mechanisms, Evasion Strategies, and Therapeutic Advances
Paula Morcillo-Martín-Romo, Javier Valverde-Pozo, María Ortiz-Bueno, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 857-857
Open Access

CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer Immunotherapy
Rosaely Casalegno‐Garduño, Alf Spitschak, Tim Pannek, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 930-930
Open Access

Advances in Gene Therapy with Oncolytic Viruses and CAR-T Cells and Therapy-Related Groups
Yasunari Matsuzaka, Ryu Yashiro
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 268-268
Open Access

Exploration of the role of immune cells and cell therapy in hepatocellular carcinoma
Tao Zhang, Chongyang Ren, Zhanyu Yang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

From Gene Editing to Tumor Eradication: The CRISPR Revolution in Cancer Therapy
Ashiq Ali, Urooj Azmat, Aisha Khatoon, et al.
Progress in Biophysics and Molecular Biology (2025)
Closed Access

Cell-based immunotherapies for solid tumors: advances, challenges, and future directions
Ting Zhao, Jinping You, Congyue Wang, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access

Page 1 - Next Page

Scroll to top